AgomAb Therapeutics NV (AGMB)

AgomAb Therapeutics NV will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

AgomAb Therapeutics NV Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.01	0.01	0.01
Debt / EBITDA Ratio	-	-0.03	-0.13
Debt / FCF Ratio	-0.03	-0.03	-0.07
Quick Ratio	-	18.79	11.25
Return on Equity (ROE)	-38.71%	-24.60%	-7.52%
Return on Assets (ROA)	-	-22.42%	-6.65%
Return on Invested Capital (ROIC)	-36.80%	-25.32%	-20.38%
Return on Capital Employed (ROCE)	-	-23.92%	-7.62%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).